Fig. 3.
Manhattan and QQ plots of SNP-based and Gene-Based female-specific GWAS results of neuropathological features of AD (n = 2660). Dotted red lines represent the threshold for genomewide significance (P < 5 × 10−8) and Bonferroni correction for the gene-based analyses. A ncAD female-specific GWAS. B Gene-based analysis for ncAD female-specific case–control sample. C Braak stage female-specific GWAS. D Gene-based analysis for Braak stage in females. E NP score female-specific GWAS. F Gene-based analysis for NP score in females
